Rubicon Genomics Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 32

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $75M

Rubicon Genomics General Information

Description

Provider of amplification technologies designed for detecting the pattern of DNA methylation in cancer cells. The company develops a test to non-invasively diagnose cancer and other diseases to amplify the exceedingly small amounts of abnormally methylated DNA that are released by diseased tissue into serum and urine, enabling physicians to access non-invasive tests for cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 4743 Venture Drive
  • Ann Arbor, MI 48108
  • United States
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 4743 Venture Drive
  • Ann Arbor, MI 48108
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rubicon Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 17-Jan-2017 $75M Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Debt - General 15-Jul-2015 Completed Generating Revenue
3. Later Stage VC (Series B1) 13-Nov-2007 Completed Generating Revenue
2. Early Stage VC 03-Jun-2005 $2.63M $4.12M Completed Startup
1. Early Stage VC (Series B) 01-Feb-2003 $1.49M $1.49M Completed Startup
To view Rubicon Genomics’s complete valuation and funding history, request access »

Rubicon Genomics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B1
Series B
Series A 875,000 $0.010000 $2 $2 1x $2 4.18%
To view Rubicon Genomics’s complete cap table history, request access »

Rubicon Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of amplification technologies designed for detecting the pattern of DNA methylation in cancer cells. The compan
Discovery Tools (Healthcare)
Ann Arbor, MI
32 As of 2015

Toronto, Canada
 

Baltimore, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rubicon Genomics Competitors (19)

One of Rubicon Genomics’s 19 competitors is Treventis, a Venture Capital-Backed company based in Toronto, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Treventis Venture Capital-Backed Toronto, Canada
Personal Genome Diagnostics Formerly VC-backed Baltimore, MD
Palvella Therapeutics Formerly VC-backed Wayne, PA
Sphere Fluidics Formerly VC-backed Cambridge, United Kingdom
New England Biolabs Corporation Ipswich, MA
You’re viewing 5 of 19 competitors. Get the full list »

Rubicon Genomics Patents

Rubicon Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2016160965-A1 Methods and compositions for repair of dna ends by multiple enzymatic activities Inactive 30-Mar-2015
WO-2016145039-A1 Enhanced fragmentation and repair of nucleic acids Inactive 10-Mar-2015
WO-2015074017-A1 Degradable adaptors for background reduction Inactive 18-Nov-2013
WO-2014071361-A1 Barcoding nucleic acids Inactive 05-Nov-2012
EP-1924704-A1 Compositions and methods for processing and amplification of dna, including using multiple enzymes in a single reaction Active 02-Aug-2005 C12P19/34
To view Rubicon Genomics’s complete patent history, request access »

Rubicon Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rubicon Genomics Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arch Development Partners Venture Capital Minority
BroadOak Capital Partners Growth/Expansion Minority
Duchossois Technology Partners Corporate Venture Capital Minority
Innovation Partnerships Venture Capital Minority
Michigan Economic Development Government
You’re viewing 5 of 8 investors. Get the full list »

Rubicon Genomics FAQs

  • When was Rubicon Genomics founded?

    Rubicon Genomics was founded in 2000.

  • Where is Rubicon Genomics headquartered?

    Rubicon Genomics is headquartered in Ann Arbor, MI.

  • What is the size of Rubicon Genomics?

    Rubicon Genomics has 32 total employees.

  • What industry is Rubicon Genomics in?

    Rubicon Genomics’s primary industry is Discovery Tools (Healthcare).

  • Is Rubicon Genomics a private or public company?

    Rubicon Genomics is a Private company.

  • What is the current valuation of Rubicon Genomics?

    The current valuation of Rubicon Genomics is .

  • What is Rubicon Genomics’s current revenue?

    The current revenue for Rubicon Genomics is .

  • How much funding has Rubicon Genomics raised over time?

    Rubicon Genomics has raised $12M.

  • Who are Rubicon Genomics’s investors?

    Arch Development Partners, BroadOak Capital Partners, Duchossois Technology Partners, Innovation Partnerships, and Michigan Economic Development are 5 of 8 investors who have invested in Rubicon Genomics.

  • Who are Rubicon Genomics’s competitors?

    Treventis, Personal Genome Diagnostics, Palvella Therapeutics, Sphere Fluidics, and New England Biolabs are some of the 19 competitors of Rubicon Genomics.

  • When was Rubicon Genomics acquired?

    Rubicon Genomics was acquired on 17-Jan-2017.

  • Who acquired Rubicon Genomics?

    Rubicon Genomics was acquired by Takara Bio USA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process